advertisement

---

Pharmaceutics 10

Showing records 1 to 10 | Display all abstracts in Pharmaceutics

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmonem R
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
García-Herranz D; Rodrigo MJ
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Elhabal SF
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Subías M
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmalak NS
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Martínez-Rincón T
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
El-Nabarawi MA
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Méndez-Martínez S
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Teaima MH
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Bravo-Osuna I; Bonet A; Ruberte J; García-Feijoó J; Pablo L; García-Martín E; Herrero-Vanrell R
Pharmaceutics 2021; 13:

---